Open access · US-GOV
via ClinicalTrials.gov Clinical trial
An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging
Authors not listed
Innovative Medical · 2007
Abstract
The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Anonymous. (2007). An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging. <em>Innovative Medical</em>. https://clinicaltrials.gov/study/NCT00492479
Vancouver
Anonymous. An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging. Innovative Medical. 2007.
BibTeX
@misc{anon2007AnEval,
title = {An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging},
author = {Anonymous},
journal = {Innovative Medical},
year = {2007},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2026
Open access · OA
Mitofusin Activation Delays Aging in Caenorhabditis elegans
Free Radical Biology and Medicine 2026
Citation only
Norathyriol delays aging through DAF-16- and SKN-1-associated antioxidant responses in Caenorhabditis elegans
Cell Death and Differentiation 2011
Open access · OA
Regulation of skin aging and heart development by TAp63
Genes & Nutrition 2006
Open access · OA
Nutrition, sirtuins and aging
Pierre Fabre Dermo Cosmetique 2024
Open access · US-GOV
Evaluation of Biological Anti-aging Efficacy of the Cosmetic Night Cream RV4983A- LA3365 in Women After 2 Months of Daily Use
Epigenomics 2016
Open access · CC-BY